Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Tefron Ltd. Capital/Financing Update 2009

Jan 12, 2009

7077_rns_2009-01-12_bc9ed5fe-8743-432d-812f-f907128ba4a1.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of The Securities Exchange Act of 1934

For the month of January, 2009

TEFRON LTD.

(Translation of registrant's name into English)

Ind. Center Teradyon, P.O. Box 1365, Misgav 20179, Israel (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F X Form 40-F _

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes __ No X

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- N/A_

10171/1250/1417531/2

Reverse Stock Split – Record Date and Effective Date

On December 18, 2008, Tefron Ltd. ("Tefron") filed a proxy statement for the convening of a special shareholders meeting of Tefron for the approval, inter alia , of a reverse stock split pursuant to which every ten ordinary shares of Tefron, NIS 1.00 nominal value per share, shall become one ordinary share with a nominal value of NIS 10.00. The shareholder meeting is scheduled to be held on January 20, 2009.

Tefron hereby notifies that, subject to the approval of Tefron's shareholders of the reverse stock split, the record date for the reverse stock split shall be the end of the trading day on January 21, 2009, and the reverse stock split shall be effected on January 22, 2009 prior to the opening of trade on the Tel Aviv Stock Exchange.

This report is filed during the period during which Tefron's shares are no longer traded on NYSE and it is not clear whether Tefron will be able to list its shares for trading on another U.S. exchange recognized for purposes of continued reporting under the dual listing rules (Chapter E3) of the Israeli Securities Law of 1968.

This Form 6-K is hereby incorporated by reference into Tefron Ltd.’s Registration Statement on Form F-3 (Registration No. 333-128847) and its Registration Statements on Form S-8 (Registration Nos. 333-139021 and 333-111932).

12_1_09

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

TEFRON LTD.

(Registrant)

By: _/s/ Eran Rotem_____ Name: Eran Rotem Title: Chief Financial Officer

By: /s/ Hanoch Zlotnik_ Name: Hanoch Zlotnik Title: Treasurer

Date: January 12, 2009

12_1_09

3